Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Deficit) (Details Textual)

v3.7.0.1
Stockholders' Equity (Deficit) (Details Textual) - USD ($)
 1 Months Ended 10 Months Ended 12 Months Ended
Dec. 12, 2016
Mar. 13, 2016
Dec. 29, 2016
Nov. 30, 2016
Oct. 25, 2016
Sep. 30, 2016
Jul. 27, 2016
Mar. 17, 2015
Dec. 31, 2015
Dec. 31, 2016
Dec. 31, 2015
Jul. 31, 2016
Jul. 26, 2016
Mar. 12, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Common Stock, Shares, Issued                 2,000,000 15,165,244 2,000,000      
Common Stock, Shares Authorized                 50,000,000 50,000,000 50,000,000 50,000,000 2,000,000  
Common Stock, Par or Stated Value Per Share                 $ 0.0001 $ 0.0001 $ 0.0001 $ 0.0001    
Common Stock, Voting Rights                   1.1        
Proceeds from Issuance or Sale of Equity                 $ 0 $ 35,008,000        
Payments for Underwriting Expense                   $ 1,400,000        
Common Stock, Shares Subscribed but Unissued                 250,000 767,264 250,000      
Common Stock, Value, Subscriptions                 $ 190,000 $ 4,396,000 $ 190,000      
Shares, Outstanding                          
Class Of Warrant Or Right, Warrants Term                   ten year term        
Class Of Warrant Or Right, Warrants Issued                   138,462        
Stock Issued During Period, Value, New Issues                   $ 39,098,000        
Payments of Stock Issuance Costs                   $ 4,090,000 $ 0      
Capital Unit [Member]                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Percentage Of Placement Agent Fee 10.00%   10.00% 10.00% 10.00%                  
Stock Issued During Period, Shares, New Issues 477,000   632,246 1,900,215 1,090,580                  
Class of Warrant or Right, Exercise Price of Warrants or Rights $ 8.50   $ 8.50 $ 8.50 $ 8.50                  
Shares Issued, Price Per Share $ 65,000   $ 65,000 $ 65,000 $ 65,000                  
Class Of Warrant Or Right, Warrants Term five-year term   five-year term five-year term Class Of Warrant Or Right, Warrants Term                  
Class Of Warrant Or Right, Warrants Issued 119,250   158,062 475,053 272,645                  
Stock Issued During Period, Value, New Issues $ 3,100,000   $ 4,100,000 $ 12,400,000                    
Payments of Stock Issuance Costs $ 310,000   $ 410,000 $ 1,200,000 $ 109,058                  
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right 2,500   2,500 2,500 2,500                  
Warrant [Member]                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Stock Issued During Period, Shares, New Issues           478,708                
Class Of Warrant Or Right, Warrants Issued                   138,462        
Warrant [Member] | Capital Unit [Member]                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Stock Issued During Period, Shares, New Issues         10,000                  
Payments of Stock Issuance Costs $ 47,700   $ 63,224 $ 190,021                    
General and Administrative Expense [Member]                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Allocated Share-based Compensation Expense                   $ 862,000        
Common Stock [Member]                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Stock Issued During Period, Shares, New Issues           1,914,833 7,000,000              
Common Stock [Member] | Capital Unit [Member]                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Stock Issued During Period, Shares, New Issues 10,000   10,000 10,000                    
Series A Preferred Stock [Member]                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Common Stock, Shares Authorized                         250,000  
Stock Issued During Period, Shares, New Issues             250,000     0        
Shares, Outstanding                 0 250,000,000 0      
Stock Issued During Period, Value, New Issues                   $ 0        
Common Class B [Member]                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Common Stock, Shares, Issued                 7,000,000 0 7,000,000      
Common Stock, Shares Authorized                       15,000,000    
Stock Issued During Period, Shares, New Issues                   0        
Shares, Outstanding                 7,000,000,000 0 7,000,000,000      
Stock Repurchased and Retired During Period, Shares             7,200,000              
Stock Issued During Period, Value, New Issues                   $ 0        
Common Class A [Member]                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Common Stock, Shares, Issued                 1,000,000 1,000,000 1,000,000      
Common Stock, Shares Authorized                       1,000,000    
Stock Issued During Period, Shares, New Issues                   0        
Shares, Outstanding                 1,000,000,000 1,000,000,000 1,000,000,000      
Stock Issued During Period, Value, New Issues                   $ 0        
Fortress Biotech, Inc [Member]                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Shares Of Common Stock, Percentage                   2.50%        
Common Stock, Value, Subscriptions                   $ 900        
Fortress Biotech, Inc [Member] | Common Stock [Member]                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Stock Issued During Period, Shares, New Issues                   150,370        
Common Stock, Shares Subscribed but Unissued                   2,000,000        
Shares Issued, Price Per Share                 $ 0.147   $ 0.147      
Fortress Biotech, Inc [Member] | Common Class B [Member]                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Common Stock, Shares, Issued   250,000                        
Common Stock, Shares Subscribed but Unissued                   7,000,000        
Diluted Outstanding Equity, Percentage   2.50%                        
City of Hope National Medical Center [Member] | License Agreement [Member]                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Stock Issued During Period, Shares, New Issues                   1,000,000        
Payment Of Upfront Fees               $ 2,000,000            
City of Hope National Medical Center [Member] | Common Class A [Member] | License Agreement [Member]                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners                   10.00%        
Shares, Outstanding                   1,000,000        
National Securities, Inc [Member] | Capital Unit [Member]                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Payments of Stock Issuance Costs         $ 710,000                  
Private Placement [Member]                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Warrant Purchase Price Per Unit           $ 65,000                
Warrants Issued           191,483                
Stock Issued During Period, Shares, New Issues           10,000                
Class of Warrant or Right, Number of Securities Called by Warrants or Rights           2,500                
Class of Warrant or Right, Exercise Price of Warrants or Rights           $ 8.50                
Proceeds from Issuance or Sale of Equity                   $ 12,400,000        
Payments for Underwriting Expense                   $ 1,300,000        
Private Placement [Member] | Capital Unit [Member]                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Stock Issued During Period, Value, New Issues         $ 7,100,000                  
Private Placement [Member] | National Holdings Corporation [Member]                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Percentage Of Placement Agent Fee           10.00%                
Percentage Of Shares Issued To Placement Agent           10.00%